PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression

Journal of Bone and Mineral Research

Volumn 29, Issue 1, 2014, Pages 55-66

  Cafforio, Paola ^a   Savonarola, Annalisa ^a   Stucci, Stefania ^a   De Matteo, Monica ^a   Tucci, Marco ^a   Brunetti, Anna Elisabetta ^a   Vecchio, Vita Mariagrazia ^a   Silvestris, Francesco ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

cell survival; Multiple myeloma; nls region; osteoclastogenesis; pthrp

Indexed keywords

CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BONE DISEASE; CANCER GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; PLASMA CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION;

CELL SURVIVAL; MULTIPLE MYELOMA; NLS REGION; OSTEOCLASTOGENESIS; PTHRP;

CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CCL2; CYCLIC AMP; DISEASE PROGRESSION; HUMANS; MULTIPLE MYELOMA; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE FRAGMENTS; PLASMA CELLS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTOR, PARATHYROID HORMONE, TYPE 1;

EID: 84890894704     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2022     Document Type: Article

References (57)

1. Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY., A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science. 1987; 237: 893-6.
2. Abou-Samra AB, Jüppner H, Force T, Freeman MW, Kong XF, Schipani E, Urena P, Richards J, Bonventre JV, Potts JT Jr, Kronenberg HM, Segre GV., Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci U S A. 1992; 89: 2732-6.
3. Mannstadt M, Jüppner H, Gardella TJ., Receptors for PTH and PTHrP: their biological importance and functional properties. Am J Physiol. 1999; 277: F665-75.
4. Maeda Y, Nakamura E, Nguyen MT, Suva LJ, Swain FL, Razzaque MS, Mackem S, Lanske B., Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc Natl Acad Sci U S A. 2007; 104: 6382-7.
5. Gerstenfeld LC, Shapiro FD., Expression of bone-specific genes by hypertrophic chondrocytes: implication of the complex functions of the hypertrophic chondrocyte during endochondral bone development. J Cell Biochem. 1996; 62: 1-9.
6. Hens JR, Wysolmerski JJ., Key stage of mammary gland development: molecular mechanisms involved in the formation of the embryonic mammary gland. Breast Cancer Res. 2005; 7: 220-4.
7. Amizuka N, Warshawsky H, Henderson JE, Goltzman D, Karaplis AC., Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol. 1994; 126: 1611-23.
8. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, Mulligan RC., Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 1994; 8: 277-89.
9. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall RE, Kemp BE, Suva LJ, Rodda CP, Ebeling PR, Hudson PJ, Zajac JD, Martin TJ., Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A. 1987; 84: 5048-52.
10. Burtis WJ, Wu T, Bunch C, Wysolmerski JJ, Insogna KL, Weir EC, Broadus AE, Stewart AF., Identification of a novel 17,000-Dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem. 1987; 262: 7151-6.
11. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, Nissenson RA., Parathyroid hormone like protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest. 1987; 80: 1803-7.
12. Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, Yoneda T, Mundy GR., Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest. 1996; 98: 1544-9.
13. Liao J, McCauley LK., Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP). Cancer Metastasis Rev. 2006; 25: 559-71.
14. Martin TJ, Moseley JM, Williams ED., Parathyroid hormone-related protein: hormone and cytokine. J Endocrinol. 1997; 154: S23-37.
15. Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, Yang KH, Vasavada RC, Weir EC, Broadus AE, Stewart AF., Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev. 1996; 76: 127-73.
16. Fiaschi-Taesch NM, Stewart AF., Minireview: parathyroid hormone-related protein as an intracrine factor-trafficking mechanisms and functional consequences. Endocrinology. 2003; 144: 407-11.
17. Shen X, Qian L, Falzon M., PTH-related protein enhances MCF-7 breast cancer cell adhesion, migration, and invasion via an intracrine pathway. Exp Cell Res. 2004; 294: 420-33.
18. Aarts MM, Levy D, He B, Stregger S, Chen T, Richard S, Henderson JE., Parathyroid hormone-related protein interacts with RNA. J Biol Chem. 1999; 274: 4832-8.
19. Sirchia R, Priulla M, Sciandrello G, Caradonna F, Barbata G, Luparello C., Mid-region parathyroid hormone-related protein (PTHrP) binds chromatin of MDA-MB231 breast cancer cells and isolated oligonucleotides in vitro . Breast Cancer Res Treat. 2007; 105: 105-16.
20. Miao D, Su H, He B, Gao J, Xia Q, Zhu M, Gu Z, Goltzman D, Karaplis AC., Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein. Proc Natl Acad Sci U S A. 2008; 105: 20309-14.
21. Toribio RE, Brown HA, Novince CM, Marlow B, Hernon K, Lanigan LG, Hildreth BE 3rd, Werbeck JL, Shu ST, Lorch G, Carlton M, Foley J, Boyaka P, McCauley LK, Rosol TJ., The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice. FASEB J. 2010; 24: 1947-57.
22. Zheng MH, McCaughan HB, Papadimitriou JM, Nicholson GC, Wood DJ., Tartrate resistant acid phosphatase activity in rat cultured osteoclasts is inhibited by a carboxyl terminal peptide (osteostatin) from parathyroid hormone-related protein. J Cell Biochem. 1994; 54: 145-53.
23. Yang KH, de Papp AE, Soifer NE, Dreyer BE, Wu TL, Porter SE, Bellantoni M, Burtis WJ, Insogna KL, Broadus AE., Parathyroid hormone-related protein: evidence for isoform- and tissue-specific posttranslational processing. Biochemistry. 1994; 33: 7460-9.
24. Orloff JJ, Reddy D, de Papp AE, Yang KH, Soifer NE, Stewart AF., Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions. Endocr Rev. 1994; 15: 40-60.
25. Wu TL, Vasavada RC, Yang K, Massfelder T, Ganz M, Abbas SK, Care AD, Stewart AF., Structural and physiologic characterization of the mid-region secretory species of parathyroid hormone-related protein. J Biol Chem. 1996; 271: 24371-81.
26. Hastings RH, Laux AM, Casillas A, Xu R, Lukas Z, Ernstrom K, Deftos LJ., Sex-specific survival advantage with parathyroid hormone-related protein in non-small cell lung carcinoma patients. Clin Cancer Res. 2006; 12: 499-506.
27. Saito H, Tsunenari T, Onuma E, Sato K, Ogata E, Yamada-Okabe H., Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231. Anticancer Res. 2005; 25: 3817-23.
28. Akino K, Ohtsuru A, Yano H, Ozeki S, Namba H, Nakashima M, Ito M, Matsumoto T, Yamashita S., Antisense inhibition of parathyroid hormone-related peptide gene expression reduces malignant pituitary tumor progression and metastases in the rat. Cancer Res. 1996; 56: 77-86.
29. Tsujimura H, Nagamura F, Iseki T, Kanazawa S, Saisho H., Significance of parathyroid hormone-related protein as a factor stimulating bone resorption and causing hypercalcemia in myeloma. Am J Hematol. 1998; 59: 168-70.
30. Ohmori M, Nagai M, Fujita M, Dobashi H, Tasaka T, Yamaoka G, Kawanishi K, Taniwaki M, Takahara J., A novel mature B-cell line (DOBIL-6) producing both parathyroid hormone-related protein and interleukin-6 from a myeloma patient presenting with hypercalcaemia. Br J Haematol. 1998; 101: 688-93.
31. Kitazawa R, Kitazawa S, Kajimoto K, Sowa H, Sugimoto T, Matsui T, Chihara K, Maeda S., Expression of parathyroid hormone-related protein (PTHrP) in multiple myeloma. Pathol Int. 2002; 52: 63-8.
32. Otsuki T, Yamada O, Kurebayashi J, Sakaguchi H, Yata K, Uno M, Oka T, Yawata Y, Ueki A., Expression and in vitro modification of parathyroid hormone related protein (PTHrP) and PTH/PTHrP-receptor in human myeloma cells. Leuk Lymphoma. 2001; 41: 397-409.
33. Sanderson RD, Epstein J., Myeloma bone disease. J Bone Miner Res. 2009; 24: 1783-8.
34. Zeimer H, Firkin F, Grill V, Slavin J, Zhou H, Martin TJ., Assessment of cellular expression of parathyroid hormone-related protein mRNA and protein in multiple myeloma. J Pathol. 2000; 192: 336-41.
35. Silvestris F, Cafforio P, De Matteo M, Calvani N, Frassanito MA, Dammacco F., Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by malignant plasma cells. Clin Cancer Res. 2008; 14: 6081-91.
36. Silvestris F, Cafforio P, Calvani N, De Matteo M, Lombardi L, Dammacco F., In-vitro functional phenotypes of plasma cell lines from patients with multiple myeloma. Leuk Lymphoma. 2006; 47: 1921-31.
37. Landriscina M, Altamura SA, Roca L, Gigante M, Piscazzi A, Cavalcanti E, Costantino E, Barone C, Cignarelli M, Gesualdo L, Ranieri E., Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma. Int J Cancer. 2008; 122: 2842-50.
38. Livak KJ, Schmittgen TD., Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCt method. Methods. 2001; 25: 402-8.
39. Silvestris F, Cafforio P, De Matteo M, Quatraro C, Dammacco F., Expression and function of the calcitonin receptor by myeloma cells in their osteoclast-like activity in vitro. Leuk Res. 2008; 32: 611-23.
40. Tucci M, Ciavarella S, Strippoli S, Brunetti O, Dammacco F, Silvestris F., Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro. Exp Hematol. 2011; 39: 773-83.
41. Tovar Sepulveda VA, Shen X, Falzon M., Intracrine PTHrP protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells. Endocrinology. 2002; 143: 596-606.
42. Bhatia V, Saini MK, Falzon M., Nuclear PTHrP targeting regulates PTHrP secretion and enhances LoVo cell growth and survival. Regul Pept. 2009; 158: 149-55.
43. Kremer R, Li J, Camirand A, Karaplis AC., Parathyroid hormone related protein (PTHrP) in tumor progression. Adv Exp Med Biol. 2011; 720: 145-60.
44. Callander NS, Roodman GD., Myeloma bone disease. Semin Hematol. 2001; 38: 276-85.
45. Clemens TL, Cormier S, Eichinger A, Endlich K, Fiaschi-Taesch N, Fischer E, Friedman PA, Karaplis AC, Massfelder T, Rossert J, Schlüter KD, Silve C, Stewart AF, Takane K, Helwig JJ., Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol. 2001; 134: 1113-36.
46. Park SI, McCauley LK., Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells. Endocr Relat Cancer. 2012; 19: 243-54.
47. Luparello C, Romanotto R, Tipa A, Sirchia R, Olmo N, Lõpez de Silanes I, Turnay J, Lizarbe MA, Stewart AF., Midregion parathyroid hormone-related protein inhibits growth and invasion in vitro and tumorigenesis in vivo of human breast cancer cells. J Bone Miner Res. 2001; 16: 2173-81.
48. Li J, Karaplis AC, Huang DC, Siegel PM, Camirand A, Yang XF, Muller WJ, Kremer R., PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target. J Clin Invest. 2011; 121: 4655-69.
49. Talon I, Lindner V, Sourbier C, Schordan E, Rothhut S, Barthelmebs M, Lang H, Helwig JJ, Massfelder T., Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo. Carcinogenesis. 2006; 27: 73-83.
50. Koski AM, Sikiö A, Forslund T., Teriparatide treatment complicated by malignant myeloma. BMJ Case Rep. 2010; 2010: bcr0120102681. doi: 10.1136/bcr.01.2010.2681
51. Maioli E, Fortino V., The complexity of parathyroid hormone-related protein signalling. Cell Mol Life Sci. 2004; 61: 257-62.
52. Lu Y, Xiao G, Galson DL, Nishio Y, Mizokami A, Keller ET, Yao Z, Zhang J., PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro. Int J Cancer. 2007; 121: 724-33.
53. Theriault RL, Theriault RL., Biology of bone metastases. Cancer Control. 2012; 19: 92-101.
54. Calvani N, Cafforio P, Silvestris F, Dammacco F., Functional osteoclast-like transformation of cultured human myeloma cell lines. Br J Haematol. 2005; 130: 926-38.
55. Shimizu H, Monden T, Tomotsune T, Nakatani Y, Domeki N, Matsumura M, Jojima T, Kawagoe Y, Kasai K., A case of myeloma with hypercalcemia caused by high serum concentrations of both parathyroid hormone-related peptide (PTHrP) and macrophage inflammatory protein-1α (MIP-1α). Intern Med. 2011; 50: 2993-6.
56. Abe M, Hiura K, Wilde J, Moriyama K, Hashimoto T, Ozaki S, Wakatsuki S, Kosaka M, Kido S, Inoue D., Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood. 2002; 100: 2195-202.
57. Kumari R, Robertson JF, Watson SA., Nuclear targeting of a midregion PTHrP fragment is necessary for stimulating growth in breast cancer cells. Int J Cancer. 2006; 119: 49-59.